590 related articles for article (PubMed ID: 31226298)
21. Pharmacologic Hemostatic Agents in Total Joint Arthroplasty-A Cost-Effectiveness Analysis.
Ramkumar DB; Ramkumar N; Tapp SJ; Moschetti WE
J Arthroplasty; 2018 Jul; 33(7):2092-2099.e9. PubMed ID: 29605152
[TBL] [Abstract][Full Text] [Related]
22. AANA Journal Course: Update for Nurse Anesthetists-Part 5-Use of Tranexamic Acid in Preventing Postpartum Hemorrhage.
Glymph DC; Tubog TD; Vedenikina M
AANA J; 2016 Dec; 84(6):427-438. PubMed ID: 28235177
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of uterine balloon tamponade devices in managing atonic post-partum hemorrhage at public health facilities in India.
Joshi BN; Shetty SS; Moray KV; Sachin O; Chaurasia H
PLoS One; 2021; 16(8):e0256271. PubMed ID: 34407132
[TBL] [Abstract][Full Text] [Related]
24. The effect of tranexamic acid on the risk of death and hysterectomy in women with post-partum haemorrhage: statistical analysis plan for the WOMAN trial.
Shakur H; Roberts I; Edwards P; Elbourne D; Alfirevic Z; Ronsmans C
Trials; 2016 May; 17(1):249. PubMed ID: 27188698
[TBL] [Abstract][Full Text] [Related]
25. An update to tranexamic acid trends during the peripartum period in the United States, 2019 to 2021.
Sterling EK; Litman EA; Dazelle WDH; Ahmadzia HK
Am J Obstet Gynecol MFM; 2023 Jun; 5(6):100933. PubMed ID: 36933804
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.
Venkatesh KK; Clark LH; Stamilio DM
Am J Obstet Gynecol; 2019 Jan; 220(1):106.e1-106.e10. PubMed ID: 30170036
[TBL] [Abstract][Full Text] [Related]
27. Tranexamic Acid for the Prevention of Blood Loss after Vaginal Delivery.
Sentilhes L; Winer N; Azria E; Sénat MV; Le Ray C; Vardon D; Perrotin F; Desbrière R; Fuchs F; Kayem G; Ducarme G; Doret-Dion M; Huissoud C; Bohec C; Deruelle P; Darsonval A; Chrétien JM; Seco A; Daniel V; Deneux-Tharaux C;
N Engl J Med; 2018 Aug; 379(8):731-742. PubMed ID: 30134136
[TBL] [Abstract][Full Text] [Related]
28. Tranexamic acid for post-partum haemorrhage: What, who and when.
Brenner A; Ker K; Shakur-Still H; Roberts I
Best Pract Res Clin Obstet Gynaecol; 2019 Nov; 61():66-74. PubMed ID: 31128974
[TBL] [Abstract][Full Text] [Related]
29. The impact of early outcome events on the effect of tranexamic acid in post-partum haemorrhage: an exploratory subgroup analysis of the WOMAN trial.
Brenner A; Shakur-Still H; Chaudhri R; Fawole B; Arulkumaran S; Roberts I;
BMC Pregnancy Childbirth; 2018 Jun; 18(1):215. PubMed ID: 29879947
[TBL] [Abstract][Full Text] [Related]
30. Influence of the WOMAN trial on national wide standard operating procedures for treatment of postpartum hemorrhage.
Raimann FJ; Jennewein L; Sonntagbauer M; Raddatz LM; Möllmann CJ; Louwen F; Zacharowski K; Weber CF
J Gynecol Obstet Hum Reprod; 2019 Apr; 48(4):269-273. PubMed ID: 30685429
[TBL] [Abstract][Full Text] [Related]
31. Tranexamic acid for treatment of primary postpartum hemorrhage after vaginal delivery: a systematic review and meta-analysis of randomized controlled trials.
Della Corte L; Saccone G; Locci M; Carbone L; Raffone A; Giampaolino P; Ciardulli A; Berghella V; Zullo F
J Matern Fetal Neonatal Med; 2020 Mar; 33(5):869-874. PubMed ID: 30122082
[No Abstract] [Full Text] [Related]
32. Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: study protocol for an international, randomised, double-blind, placebo-controlled trial.
Ker K; Roberts I; Chaudhri R; Fawole B; Beaumont D; Balogun E; Prowse D; Pepple T; Javaid K; Kayani A; Arulkumaran S; Bates I; Shakur-Still H;
Trials; 2018 Dec; 19(1):712. PubMed ID: 30594227
[TBL] [Abstract][Full Text] [Related]
33. Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum.
Peitsidis P; Kadir RA
Expert Opin Pharmacother; 2011 Mar; 12(4):503-16. PubMed ID: 21294602
[TBL] [Abstract][Full Text] [Related]
34. The Use of Tranexamic Acid to Prevent Postpartum Hemorrhage.
Mielke RT; Obermeyer S
J Midwifery Womens Health; 2020 May; 65(3):410-416. PubMed ID: 32431098
[TBL] [Abstract][Full Text] [Related]
35. Tranexamic acid at cesarean delivery: drug-error deaths.
Moran NF; Bishop DG; Fawcus S; Morris E; Shakur-Still H; Devall AJ; Gallos ID; Widmer M; Oladapo OT; Coomarasamy A; Hofmeyr GJ
Am J Obstet Gynecol; 2023 Jan; 228(1):1-4. PubMed ID: 36279937
[TBL] [Abstract][Full Text] [Related]
36. State Perinatal Quality Collaborative for Reducing Severe Maternal Morbidity From Hemorrhage: A Cost-Effectiveness Analysis.
Wiesehan EC; Keesara SR; Krissberg JR; Main EK; Goldhaber-Fiebert JD
Obstet Gynecol; 2023 Feb; 141(2):387-394. PubMed ID: 36649352
[TBL] [Abstract][Full Text] [Related]
37. Policy of high-dose tranexamic acid for treating postpartum hemorrhage after vaginal delivery.
Bouet PE; Ruiz V; Legendre G; Gillard P; Descamps P; Sentilhes L
J Matern Fetal Neonatal Med; 2016; 29(10):1617-22. PubMed ID: 26118386
[TBL] [Abstract][Full Text] [Related]
38. The Role of Perinatal Nurses in the Use of Tranexamic Acid During Postpartum Hemorrhage.
Obermeyer S; Mielke RT; Lederhos HL
Nurs Womens Health; 2022 Feb; 26(1):63-71. PubMed ID: 35065079
[TBL] [Abstract][Full Text] [Related]
39. Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery.
Sentilhes L; Sénat MV; Le Lous M; Winer N; Rozenberg P; Kayem G; Verspyck E; Fuchs F; Azria E; Gallot D; Korb D; Desbrière R; Le Ray C; Chauleur C; de Marcillac F; Perrotin F; Parant O; Salomon LJ; Gauchotte E; Bretelle F; Sananès N; Bohec C; Mottet N; Legendre G; Letouzey V; Haddad B; Vardon D; Madar H; Mattuizzi A; Daniel V; Regueme S; Roussillon C; Benard A; Georget A; Darsonval A; Deneux-Tharaux C;
N Engl J Med; 2021 Apr; 384(17):1623-1634. PubMed ID: 33913639
[TBL] [Abstract][Full Text] [Related]
40. Tranexamic acid for bleeding: Much more than a treatment for postpartum hemorrhage.
Roberts I; Brenner A; Shakur-Still H
Am J Obstet Gynecol MFM; 2023 Feb; 5(2S):100722. PubMed ID: 35988879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
